Loading insider details...
Latest Form 4 (Jun 9, 2026): Sale of 1,190 XENE shares, $63.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 1,190 | $63.2K |
| Jun 4, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 2,645 | n/a |
| Sep 12, 2025 | CORCEPT THERAPEUTICS INC (CORT) | Gift | 7,393 | n/a |
| Sep 9, 2025 | CORCEPT THERAPEUTICS INC (CORT) | Exercise/Conversion | 11,000 | $252.9K |
| Jun 13, 2025 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 15,000 | n/a |
| Jun 6, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 17,012 | n/a |
| Jun 5, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 15,542 | n/a |
| May 21, 2024 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 30,000 | n/a |
| Aug 10, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 28,000 | n/a |
| May 23, 2023 | CORCEPT THERAPEUTICS INC (CORT) | Grant/Award | 30,000 | n/a |